InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
13
Disclosed sells
0
T+90 hit rate
22%
T+90 mean return
-27.0%
Across 23 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Finley John David, Chief Financial Officer. Officer active across 1 company, notably Palisade Bio, INC.. Aggregated, 29 filings have been recorded. Split: 13 buys · 0 sell. Total volume traded: €82k. History available since 27 August 2021. The latest transaction was disclosed on 28 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations29 total
1,622 shares0Common Stock, par value $0.01SEC:0001493152-24-022037:0
1,000 shares@ US$4.814.9% of flowCommon Stock, par value $0.01SEC:0001493152-24-021431:0
Canonical exit: 22 Aug 2024 (T+90)
666 shares@ US$4.97253.4% of flowCommon Stock, par value $0.01SEC:0001493152-24-021045:0
232 shares0Common Stock, par value $0.01SEC:0001493152-24-018282:0
5,558 shares0Common Stock, par value $0.01SEC:0001493152-24-009709:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-24-005480:0
10,000 shares@ US$0.46924.9% of flowCommon Stock, par value $0.01SEC:0001493152-24-005207:0
Canonical exit: 6 May 2024 (T+90)
10,000 shares@ US$0.5595.7% of flowCommon Stock, par value $0.01SEC:0001493152-24-004566:0
Canonical exit: 30 Apr 2024 (T+90)
1,309 shares0Common Stock, par value $0.01SEC:0001493152-24-001394:0
5,559 shares0Common Stock, par value $0.01SEC:0001493152-23-045474:0
10,000 shares@ US$0.515.2% of flowCommon Stock, par value $0.01SEC:0001493152-23-042663:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-039936:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-036404:0
15,000 shares@ US$0.539211.3% of flowCommon Stock, par value $0.01SEC:0001493152-23-034754:0
Canonical exit: 26 Dec 2023 (T+90)
15,000 shares@ US$0.65510.2% of flowCommon Stock, par value $0.01SEC:0001493152-23-032655:0
Canonical exit: 12 Dec 2023 (T+90)
5,558 shares0Common Stock, par value $0.01SEC:0001493152-23-032505:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-028702:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-023867:0
3,475 shares0Common Stock, par value $0.01SEC:0001493152-23-021308:0
1,309 shares0Common Stock, par value $0.01SEC:0001493152-23-011080:0
19,481.242 shares@ US$0.14373.1% of flowCommon Stock, par value $0.01SEC:0001493152-22-025023:0
Canonical exit: 30 Nov 2022 (T+90)
7,350 shares@ US$0.161.3% of flowCommon Stock, par value $0.01SEC:0001493152-22-024082:0
Canonical exit: 21 Nov 2022 (T+90)
100,000 shares@ US$0.2527.3% of flowCommon Stock, par value $0.01SEC:0001493152-22-023510:0
Canonical exit: 14 Nov 2022 (T+90)
12,545 shares0Common StockSEC:0001209191-22-026450:0
7,500 shares@ US$1.08990.0020% mcap32.4% of flowCommon StockSEC:0001209191-22-021051:0
Canonical exit: 22 Jun 2022 (T+90)
25 of 29 declarations
About Finley John David
Finley John David is the Chief Financial Officer at Palisade Bio, Inc. He is responsible for financial management and economic strategy for the company. His expertise in finance is essential to ensure the financial health and sustainable growth of Palisade Bio.
